Back

Regnase-1 overexpression as a novel gene therapy approach for pulmonary hypertension

26 August 2022 (13:15 - 14:00)
Organised by:
Congress Presentation Part of: New insights and therapeutic options in pulmonary arterial hypertension Hypertension, Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Anca Remes

Christian-Albrechts-University Kiel, Kiel (Germany)

6 More presentations in this session

Presentation thumbnail
Focused ultrasound stimulation of the inflammatory reflex at the spleen ameliorates pulmonary arterial hypertension in rodents
Doctor S. Zafeiropoulos (Zurich, CH)
Abstract Slides
Presentation thumbnail
A miRNA derived from the 17/92 cluster is a novel player in programming pulmonary hypertension in response to gestational hypoxia via NADPH oxidases and the mTOR pathway
Ms Y. Qin (Munich, DE)
Abstract Slides
Presentation thumbnail
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice
Mr Y. Chou (New Taipei, TW)
Abstract Slides
Presentation thumbnail
Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease
Mr S. Huertas Nieto (Santa Cruz de Tenerife, ES)
Abstract Slides
Presentation thumbnail
Transcriptomic profiling reveals connection to lung autonomic nervous system dysfunction and inflammation in pulmonary artery hypertension rats
Doctor T. Tan (Wuhan, CN)
Abstract Slides

Access the full session

Session thumbnail
New insights and therapeutic options in pulmonary arterial hypertension

The Event

Event poster

ESC Congress 2022

26 August 2022 13:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources